The Iowa primary is set for Tuesday, June 2. News 8 has everything you need to know about who's running and how to cast your ...
Mykhailo Mudryk could be available to return to the pitch in December 2026 – but his future at Chelsea is all-but over.
The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug ...
The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the ...
May 1 (Reuters) - The U.S. Food and Drug Administration has authorized the granting of early access before regulatory ...
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the most significant change to U.S. cosmetic regulation since the Federal Food, Drug, and Cosmetic Act (FD&C Act) was enacted in 1938.
Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
Key Takeaways FDA has proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list. The proposal would materially limit 503B bulk compounding of these GLP-1 products. Comments ...
Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...
Expert insights on QMSR compliance: transition steps, gap assessments, risk-based approach, and global harmonization with ISO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results